A lexey Repik is a Russian entrepreneur who founded and owns R-Pharm, one of Russia's largest pharmaceutical companies. He started his career in healthcare in the 1990s and founded R-Pharm in 2001. The company began as a distributor of drugs for other manufacturers, but Repik strategically pivoted the business towards manufacturing its own pharmaceuticals.

R-Pharm has become a major producer of a wide range of medicines, including high-tech cancer drugs and, more recently, Covid-19 treatments and vaccines. The company has been a significant beneficiary of the Russian government's import substitution program, which aims to boost domestic production of critical goods, including pharmaceuticals. R-Pharm is a major supplier to the Russian state healthcare system, securing large government contracts that have fueled its rapid growth. Repik has become one of the most influential figures in Russia's pharmaceutical industry.